Impact of Cannabinoids on Menopause Symptoms — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Impact of Cannabinoids on Menopause Symptoms — Stella

Home/Perimenopause/

View on ClinicalTrials.gov

Recruiting

Back to Perimenopause trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Washington State University - Pullman Campus, Pullman, Washington

Key details

Phase

Safety & dosing

Sponsor

Washington State University

Collaborators

Terra Mater Botanicals Pty Ltd

Enrollment target

~100 participants

Started

March 2025

Primary completion

January 2027

Age range

40 Years – 60 Years

Sex

Female only

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.